PURA Confirms Earnings Update Covering 48% Revenue Growth, Dividend Expectations And Ongoing Acquisition Plans Scheduled For Tomorrow August 25, 2020

Dallas, TX – August 24, 2020 – — Puration, Inc. (OTC PINK: PURA) today confirmed a scheduled earnings update to be published tomorrow, Tuesday, August 25, 2020.  In addition to reviewing the company’s year to date (YTD) performance after publishing its Q2 2020 financial report, the update will include new information on the company’s ongoing acquisition campaign to expand its CBD infused consumer product reach. The update will also include the latest on the issuance of a dividend distribution to PURA shareholders resulting from the recent declaration of a stock dividend in conjunction with the sale of PURA’s cannabis cultivation operation. The update will further include information on a potential sale of a legacy water purification asset that could include another dividend distribution to PURA shareholders.

PURA just reported $1.6 million in sales year to date through Q2 2020. The company reported just shy of $1.1 million for the same period last year. PURA’s sales growth YTD compared to the same period last year is 48%.

For more information on Puration, visit

Disclaimer/Safe Harbor:

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Puration, Inc.
Brian Shibley,
(800) 861-1350


Mcap MediaWire - Costumer Service

Translate »